Environmental Risk Factors for Inflammatory Bowel Diseases: an Umbrella Review of Meta-analyses.

BACKGROUND & AIMS Multiple environmental factors have been associated with development of inflammatory bowel diseases (IBD). We performed an umbrella review of meta-analyses to summarize available epidemiologic evidence and assess its credibility. METHODS We systematically identified and appraised meta-analyses of observational studies examining environmental factors and risk of IBD (Crohn's disease [CD] or ulcerative colitis [UC]). For each meta-analysis we considered the random-effects estimate, its 95% CI, the estimates of heterogeneity and small-study effects, and graded the evidence according to prespecified criteria. Methodologic quality was assessed using AMSTAR 2. RESULTS We examined 183 estimates in 53 meta-analyses of 71 environmental factors related to lifestyles and hygiene, surgeries, drug exposures, diet, microorganisms, and vaccinations. We identified 9 factors that increase risk of IBD: smoking (CD), urban living (CD and IBD), appendectomy (CD), tonsillectomy (CD), antibiotic exposure (IBD), oral contraceptive use (IBD), consumption of soft drinks (UC), vitamin D deficiency (IBD), and non-Helicobacter pylori-like enterohepatic Helicobacter species (IBD). We identified 7 factors that reduce risk of IBD: physical activity (CD), breastfeeding (IBD), bed sharing (CD), tea consumption (UC), high levels of folate (IBD), high levels of vitamin D (CD), Helicobacter pylori infection (CD, UC, and IBD). Epidemiologic evidence for all these associations were of high to moderate strength; we identified another 11 factors associated with increased risk and 16 factors associated with reduced risk with weak credibility. Methodologic quality varied considerably among meta-analyses. Several associations were based on findings from retrospective studies, so it is not possible to determine if these are effects of IBD or results of recall bias. CONCLUSIONS In an umbrella review of meta-analyses, we found varying levels of evidence for associations of different environmental factors with risk of IBD. High-quality prospective studies with analyses of samples from patients with recent diagnoses of IBD are needed to determine whether these factors cause or are results of IBD, and their pathogenic mechanisms.

[1]  Jennifer L Lund,et al.  Burden and Cost of Gastrointestinal, Liver, and Pancreatic Diseases in the United States: Update 2018. , 2019, Gastroenterology.

[2]  Y. Zhang,et al.  Urban–rural environmental exposure during childhood and subsequent risk of inflammatory bowel disease: a meta-analysis , 2018, Expert review of gastroenterology & hepatology.

[3]  S. Brant,et al.  Smoking and Inflammatory Bowel Disease: A Comparison of China, India, and the USA , 2018, Digestive Diseases and Sciences.

[4]  J. Norman,et al.  Long-term risks and benefits associated with cesarean delivery for mother, baby, and subsequent pregnancies: Systematic review and meta-analysis , 2018, PLoS medicine.

[5]  Nima Hamidi,et al.  Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies , 2017, The Lancet.

[6]  Yali Lv,et al.  Is cytomegalovirus infection related to inflammatory bowel disease, especially steroid-resistant inflammatory bowel disease? A meta-analysis , 2017, Infection and drug resistance.

[7]  Qiu Zhao,et al.  Systematic review and meta-analysis of epidemiological studies , 2017 .

[8]  J. Fichna,et al.  Fat-soluble Vitamin Deficiencies and Inflammatory Bowel Disease: Systematic Review and Meta-Analysis , 2017, Journal of clinical gastroenterology.

[9]  A. Ananthakrishnan,et al.  Systematic review with meta‐analysis: breastfeeding and the risk of Crohn's disease and ulcerative colitis , 2017, Alimentary pharmacology & therapeutics.

[10]  Jing Liu,et al.  Carbohydrate and protein intake and risk of ulcerative colitis: Systematic review and dose-response meta-analysis of epidemiological studies. , 2017, Clinical nutrition.

[11]  P. Tugwell,et al.  AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both , 2017, British Medical Journal.

[12]  Douglas L. Nguyen,et al.  Exposure to oral contraceptives increases the risk for development of inflammatory bowel disease: a meta-analysis of case-controlled and cohort studies , 2017, European journal of gastroenterology & hepatology.

[13]  J. Rioux,et al.  Genetic Factors Interact With Tobacco Smoke to Modify Risk for Inflammatory Bowel Disease in Humans and Mice. , 2017, Gastroenterology.

[14]  Y. Tan,et al.  Macronutrient Intake and Risk of Crohn’s Disease: Systematic Review and Dose–Response Meta-Analysis of Epidemiological Studies , 2017, Nutrients.

[15]  Dong Li,et al.  Associations between Folate and Vitamin B12 Levels and Inflammatory Bowel Disease: A Meta-Analysis , 2017, Nutrients.

[16]  H. Morishita,et al.  Tooth-Matrix Biomarkers to Reconstruct Critical Periods of Brain Plasticity , 2017, Trends in Neurosciences.

[17]  Qiu Zhao,et al.  Fat intake and risk of ulcerative colitis: Systematic review and dose–response meta‐analysis of epidemiological studies , 2017, Journal of gastroenterology and hepatology.

[18]  S. Riordan,et al.  Erratum: Genome analysis of Campylobacter concisus strains from patients with inflammatory bowel disease and gastroenteritis provides new insights into pathogenicity , 2016, Scientific Reports.

[19]  David C. Wilson,et al.  Genome-wide association study implicates immune activation of multiple integrin genes in inflammatory bowel disease , 2016, Nature Genetics.

[20]  S. Ng,et al.  Understanding and Preventing the Global Increase of Inflammatory Bowel Disease. , 2017, Gastroenterology.

[21]  S. Riordan,et al.  Genome analysis of Campylobacter concisus strains from patients with inflammatory bowel disease and gastroenteritis provides new insights into pathogenicity , 2016, Scientific Reports.

[22]  Xiao-Yong Wang,et al.  Association between physical activity and inflammatory bowel disease risk: A meta-analysis. , 2016, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[23]  Fachao Zhi,et al.  Lower Level of Bacteroides in the Gut Microbiota Is Associated with Inflammatory Bowel Disease: A Meta-Analysis , 2016, BioMed research international.

[24]  Junchao Wu,et al.  Meta-analysis of the association between appendiceal orifice inflammation and appendectomy and ulcerative colitis. , 2016, Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva.

[25]  Weili Sun,et al.  Tonsillectomy and the risk of inflammatory bowel disease: A systematic review and meta‐analysis , 2016, Journal of gastroenterology and hepatology.

[26]  John P A Ioannidis,et al.  Exposure‐wide epidemiology: revisiting Bradford Hill , 2016, Statistics in medicine.

[27]  Ahmad Esmaillzadeh,et al.  Vitamin D status in relation to Crohn's disease: Meta-analysis of observational studies. , 2016, Nutrition.

[28]  Xiaoping Zhou,et al.  Tonsillectomy and inflammatory bowel disease: a meta‐analysis , 2016, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[29]  M. Frisch,et al.  Reduced risk of UC in families affected by appendicitis: a Danish national cohort study , 2016, Gut.

[30]  A. Ananthakrishnan,et al.  Environmental Hygiene and Risk of Inflammatory Bowel Diseases: A Systematic Review and Meta-analysis , 2016, Inflammatory bowel diseases.

[31]  C. Buskens,et al.  The Link between the Appendix and Ulcerative Colitis: Clinical Relevance and Potential Immunological Mechanisms , 2016, The American Journal of Gastroenterology.

[32]  M. Bechtold,et al.  Does exposure to isotretinoin increase the risk for the development of inflammatory bowel disease? A meta-analysis , 2015, European journal of gastroenterology & hepatology.

[33]  Youming Li,et al.  Body Mass Index Is Associated with Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis , 2015, PloS one.

[34]  X. Xue,et al.  Systematic review and meta-analysis of lactose digestion, its impact on intolerance and nutritional effects of dairy food restriction in inflammatory bowel diseases , 2015, Nutrition Journal.

[35]  F. Cominelli,et al.  Association Between Inflammatory Bowel Disease and Vitamin D Deficiency: A Systematic Review and Meta-analysis , 2015, Inflammatory bowel diseases.

[36]  Jun Yu Li,et al.  Meat intake and risk of inflammatory bowel disease: A meta-analysis. , 2015, The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology.

[37]  Minhu Chen,et al.  Enterohepatic Helicobacter Species as a Potential Causative Factor in Inflammatory Bowel Disease , 2015, Medicine.

[38]  N. Kaakoush,et al.  Dual role of Helicobacter and Campylobacter species in IBD: a systematic review and meta-analysis , 2015, Gut.

[39]  A. Zullo,et al.  Linking estrogen receptor β expression with inflammatory bowel disease activity , 2015, Oncotarget.

[40]  Dongfeng Zhang,et al.  Dietary fiber intake reduces risk of inflammatory bowel disease: result from a meta-analysis. , 2015, Nutrition research.

[41]  L. Dauchet,et al.  Vaccination and Risk for Developing Inflammatory Bowel Disease: A Meta-Analysis of Case-Control and Cohort Studies. , 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[42]  A. Petersen,et al.  Intestinal colonization with phylogenetic group B2 Escherichia coli related to inflammatory bowel disease: a systematic review and meta-analysis , 2015, Scandinavian journal of gastroenterology.

[43]  Chao Lu,et al.  Association between 25(OH)D Level, Ultraviolet Exposure, Geographical Location, and Inflammatory Bowel Disease Activity: A Systematic Review and Meta-Analysis , 2015, PloS one.

[44]  Dongfeng Zhang,et al.  Consumption of vegetables and fruit and the risk of inflammatory bowel disease: a meta-analysis , 2015, European journal of gastroenterology & hepatology.

[45]  A Rajić,et al.  The zoonotic potential of Mycobacterium avium ssp. paratuberculosis: a systematic review and meta-analyses of the evidence , 2015, Epidemiology and Infection.

[46]  Fang-yu Wang,et al.  Helicobacter pylori infection and inflammatory bowel disease in Asians: a meta-analysis. , 2015, World journal of gastroenterology.

[47]  C. O'Morain,et al.  The association between Helicobacter pylori infection and inflammatory bowel disease based on meta-analysis , 2015, United European gastroenterology journal.

[48]  Ashwin N. Ananthakrishnan,et al.  Epidemiology and risk factors for IBD , 2015, Nature Reviews Gastroenterology &Hepatology.

[49]  J. Ioannidis,et al.  Environmental risk factors and multiple sclerosis: an umbrella review of systematic reviews and meta-analyses , 2015, The Lancet Neurology.

[50]  J. Ioannidis,et al.  Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies , 2015, BMJ : British Medical Journal.

[51]  C. Bernstein,et al.  Antibiotics Associated With Increased Risk of New-Onset Crohn’s Disease But Not Ulcerative Colitis: A Meta-Analysis , 2014, The American Journal of Gastroenterology.

[52]  S. Ng,et al.  Environmental risk factors in inflammatory bowel disease: a population-based case-control study in Asia-Pacific , 2014, Gut.

[53]  K. Whelan,et al.  Smoking in inflammatory bowel disease: impact on disease course and insights into the aetiology of its effect. , 2014, Journal of Crohn's & colitis.

[54]  S. Bhattacharya,et al.  Mode of Delivery and Risk of Inflammatory Bowel Disease in the Offspring: Systematic Review and Meta-analysis of Observational Studies , 2014, Inflammatory bowel diseases.

[55]  L. Gu,et al.  Cesarean delivery and risk of inflammatory bowel disease: a systematic review and meta-analysis , 2014, Scandinavian journal of gastroenterology.

[56]  R. Xavier,et al.  Genetic Polymorphisms in Metabolizing Enzymes Modifying the Association Between Smoking and Inflammatory Bowel Diseases , 2014, Inflammatory bowel diseases.

[57]  A. Kostic,et al.  The microbiome in inflammatory bowel disease: current status and the future ahead. , 2014, Gastroenterology.

[58]  J. Ioannidis,et al.  Vitamin D and multiple health outcomes: umbrella review of systematic reviews and meta-analyses of observational studies and randomised trials , 2014, BMJ : British Medical Journal.

[59]  Jun Shen,et al.  Association between Faecalibacterium prausnitzii Reduction and Inflammatory Bowel Disease: A Meta-Analysis and Systematic Review of the Literature , 2014, Gastroenterology research and practice.

[60]  Se Jin Song,et al.  The treatment-naive microbiome in new-onset Crohn's disease. , 2014, Cell host & microbe.

[61]  H. Burr,et al.  Job Strain and the Risk of Inflammatory Bowel Diseases: Individual-Participant Meta-Analysis of 95 000 Men and Women , 2014, PloS one.

[62]  V. Johnson Revised standards for statistical evidence , 2013, Proceedings of the National Academy of Sciences.

[63]  S. Vermeire,et al.  Autophagy: a new target or an old strategy for the treatment of Crohn's disease? , 2013, Nature Reviews Gastroenterology &Hepatology.

[64]  W. D. de Villiers,et al.  Green Tea Polyphenols and Sulfasalazine have Parallel Anti-Inflammatory Properties in Colitis Models , 2013, Front. Immunol..

[65]  Katherine J. Lee,et al.  Current knowledge and systematic review of viruses associated with Crohn's disease , 2013, Reviews in medical virology.

[66]  M. Etminan,et al.  Isotretinoin and risk for inflammatory bowel disease: a nested case-control study and meta-analysis of published and unpublished data. , 2013, JAMA dermatology.

[67]  S. Ng,et al.  Geographical variability and environmental risk factors in inflammatory bowel disease , 2013, Gut.

[68]  Rafael Bargiela,et al.  Gut microbiota disturbance during antibiotic therapy: a multi-omic approach , 2012, Gut.

[69]  Francisco Guarner,et al.  The gut microbiota in IBD , 2012, Nature Reviews Gastroenterology &Hepatology.

[70]  J. Ioannidis The importance of potential studies that have not existed and registration of observational data sets. , 2012, JAMA.

[71]  S. Ng,et al.  Smokers with active Crohn's disease have a clinically relevant dysbiosis of the gastrointestinal microbiota* , 2012, Inflammatory bowel diseases.

[72]  B. Sands Within you, without you: is gastroenterology ready to embrace the "exposome"? , 2012, Gastroenterology.

[73]  G. Kaplan,et al.  The relationship between urban environment and the inflammatory bowel diseases: a systematic review and meta-analysis , 2012, BMC Gastroenterology.

[74]  L. Hoffman‐Goetz,et al.  Exercise Training Reduces Inflammatory Mediators in the Intestinal Tract of Healthy Older Adult Mice* , 2012, Canadian Journal on Aging / La Revue canadienne du vieillissement.

[75]  S. Westphal,et al.  Green tea polyphenol epigallocatechin-3-gallate shows therapeutic antioxidative effects in a murine model of colitis. , 2012, Journal of Crohn's & colitis.

[76]  D. Merrell,et al.  The Immunomodulatory Properties of Helicobacter pylori Confer Protection Against Allergic and Chronic Inflammatory Disorders , 2012, Front. Cell. Inf. Microbio..

[77]  Herman I. May,et al.  Exercise-induced BCL2-regulated autophagy is required for muscle glucose homeostasis , 2012, Nature.

[78]  M. Raftery,et al.  Immunoreactive proteins of Campylobacter concisus, an emergent intestinal pathogen. , 2011, FEMS immunology and medical microbiology.

[79]  John P A Ioannidis,et al.  Prognostic effect size of cardiovascular biomarkers in datasets from observational studies versus randomised trials: meta-epidemiology study , 2011, BMJ : British Medical Journal.

[80]  Douglas G Altman,et al.  How to obtain the P value from a confidence interval , 2011, BMJ : British Medical Journal.

[81]  J. Ioannidis,et al.  Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials , 2011, BMJ : British Medical Journal.

[82]  J. Ioannidis,et al.  The False-positive to False-negative Ratio in Epidemiologic Studies , 2011, Epidemiology.

[83]  R. Xavier,et al.  Genetics and pathogenesis of inflammatory bowel disease , 2011, Nature.

[84]  Takuya Suzuki,et al.  Role of flavonoids in intestinal tight junction regulation. , 2011, The Journal of nutritional biochemistry.

[85]  Philippe Seksik,et al.  Epidemiology and natural history of inflammatory bowel diseases. , 2011, Gastroenterology.

[86]  J. Rubenstein,et al.  Helicobacter pylori DNA decreases pro-inflammatory cytokine production by dendritic cells and attenuates dextran sodium sulphate-induced colitis , 2011, Gut.

[87]  G. Hunninghake,et al.  Identification of an Autophagy Defect in Smokers’ Alveolar Macrophages , 2010, The Journal of Immunology.

[88]  S. Duncan,et al.  Translocation of Crohn's disease Escherichia coli across M-cells: contrasting effects of soluble plant fibres and emulsifiers , 2010, Gut.

[89]  M. Dave,et al.  Association between Helicobacter pylori infection and inflammatory bowel disease: A meta‐analysis and systematic review of the literature† , 2010, Inflammatory bowel diseases.

[90]  B. Nordestgaard,et al.  Penetrance of NOD2/CARD15 genetic variants in the general population , 2010, Canadian Medical Association Journal.

[91]  J. Bach,et al.  The ‘hygiene hypothesis’ for autoimmune and allergic diseases: an update , 2010, Clinical and experimental immunology.

[92]  E. von Mutius,et al.  Maternal farm exposure modulates neonatal immune mechanisms through regulatory T cells. , 2009, The Journal of allergy and clinical immunology.

[93]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. , 2009, Journal of clinical epidemiology.

[94]  M. D’Elios,et al.  The neutrophil‐activating protein of Helicobacter pylori down‐modulates Th2 inflammation in ovalbumin‐induced allergic asthma , 2008, Cellular microbiology.

[95]  Les Dethlefsen,et al.  The Pervasive Effects of an Antibiotic on the Human Gut Microbiota, as Revealed by Deep 16S rRNA Sequencing , 2008, PLoS biology.

[96]  G. Kaplan,et al.  The Risk of Developing Crohn's Disease After an Appendectomy: A Meta-Analysis , 2008, The American Journal of Gastroenterology.

[97]  Johan Garssen,et al.  Breast-feeding and its role in early development of the immune system in infants: consequences for health later in life. , 2008, The Journal of nutrition.

[98]  P. Tekkis,et al.  The Risk of Oral Contraceptives in the Etiology of Inflammatory Bowel Disease: A Meta-Analysis , 2008, The American Journal of Gastroenterology.

[99]  J. Lewis,et al.  Passive Smoking and Inflammatory Bowel Disease: A Meta-Analysis , 2008, The American Journal of Gastroenterology.

[100]  P. Hunter,et al.  Detection of Mycobacterium avium subspecies paratuberculosis from patients with Crohn's disease using nucleic acid‐based techniques: A systematic review and meta‐analysis , 2008, Inflammatory bowel diseases.

[101]  J. Meddings The significance of the gut barrier in disease , 2007, Gut.

[102]  S. Pocock,et al.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies , 2007, The Lancet.

[103]  M. Egger,et al.  Mycobacterium avium subspecies paratuberculosis and Crohn's disease: a systematic review and meta-analysis. , 2007, The Lancet. Infectious diseases.

[104]  Piet A van den Brandt,et al.  Gut microbiota composition and development of atopic manifestations in infancy: the KOALA Birth Cohort Study , 2006, Gut.

[105]  R. Straub,et al.  Estrogens and Autoimmune Diseases , 2006, Annals of the New York Academy of Sciences.

[106]  S. Galandiuk,et al.  Smoking and inflammatory bowel disease: a meta-analysis. , 2006, Mayo Clinic proceedings.

[107]  S. Reif,et al.  Breastfeeding and risk of inflammatory bowel disease: a systematic review with meta-analysis. , 2004, The American journal of clinical nutrition.

[108]  D. Altman,et al.  Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.

[109]  Douglas G Altman,et al.  Interaction revisited: the difference between two estimates , 2003, BMJ : British Medical Journal.

[110]  S. Thompson,et al.  Quantifying heterogeneity in a meta‐analysis , 2002, Statistics in medicine.

[111]  M. Sopori,et al.  Effects of cigarette smoke on the immune system , 2002, Nature Reviews Immunology.

[112]  S. Chinn A simple method for converting an odds ratio to effect size for use in meta-analysis. , 2000, Statistics in medicine.

[113]  I. Olkin,et al.  Meta-analysis of observational studies in epidemiology - A proposal for reporting , 2000 .

[114]  A. Lavy,et al.  Lack of association between smoking and Crohn's disease but the usual association with ulcerative colitis in Jewish patients in Israel: a multicenter study , 2000, American Journal of Gastroenterology.

[115]  I. Vlachonikolis,et al.  Appendectomy and the development of ulcerative colitis: results of a metaanalysis of published case-control studies , 2000, American Journal of Gastroenterology.

[116]  G. Smith,et al.  Bias in meta-analysis detected by a simple, graphical test , 1997, BMJ.

[117]  R. Eliakim,et al.  The Association Between Smoking and Inflammatory Bowel Disease Among Israeli Jewish Patients , 1997, Inflammatory bowel diseases.

[118]  G. May,et al.  Meta-analysis of the role of oral contraceptive agents in inflammatory bowel disease. , 1995, Gut.

[119]  N. Arber,et al.  Lack of association between smoking and inflammatory bowel disease in Jewish patients in Israel. , 1995, Gastroenterology.

[120]  C. Begg,et al.  Operating characteristics of a rank correlation test for publication bias. , 1994, Biometrics.

[121]  B. Calkins A meta-analysis of the role of smoking in inflammatory bowel disease , 1989, Digestive diseases and sciences.